Pemetrexed plus Platinum Chemotherapy with or Without Immuno Responses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions Therapy in Non-Squamous NSCLC: Descriptive Safety Analysis

被引：0
|
作者：
Li, X.
Li, J.
机构：
[1] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
bevacizumab; Cisplatin; malignant pleural effusion;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-041
引用
收藏
页码：S2084 / S2084
页数：1
相关论文
共 50 条
  • [31] Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group
    N. Kentepozidis
    A. Kotsakis
    A. Soultati
    S. Agelaki
    Ch. Christophylakis
    M. Agelidou
    L. Chelis
    P. Papakotoulas
    L. Vamvakas
    Z. Zafiriou
    G. Samonis
    V. Georgoulias
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 605 - 612
  • [32] First-line chemotherapy plus immune checkpoint inhibitors or bevacizumab in advanced non-squamous non-small-cell lung cancer without EGFR mutations or ALK fusions
    Jiang, Panpan
    Geng, Luying
    Mao, Ziyang
    Wang, Qinyang
    Wang, Wenjuan
    Jiao, Min
    Yao, Yu
    Chen, Nanzheng
    Zhang, Jia
    Nan, Kejun
    Shen, Yuan
    Guo, Hui
    Jiang, Lili
    IMMUNOTHERAPY, 2022, 14 (06) : 445 - 457
  • [33] Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study
    Koji Nishimoto
    Masato Karayama
    Naoki Inui
    Hideki Yasui
    Hironao Hozumi
    Yuzo Suzuki
    Kazuki Furuhashi
    Tomoyuki Fujisawa
    Noriyuki Enomoto
    Yutaro Nakamura
    Nao Inami
    Shun Matsuura
    Yusuke Kaida
    Takashi Matsui
    Kazuhiro Asada
    Hiroyuki Matsuda
    Masato Fujii
    Mikio Toyoshima
    Shiro Imokawa
    Takafumi Suda
    Medical Oncology, 2018, 35
  • [34] Cost-effectiveness analysis of the addition of bevacizumab to chemotherapy as induction and maintenance therapy for metastatic non-squamous non-small-cell lung cancer
    Zheng, H.
    Xie, L.
    Zhan, M.
    Wen, F.
    Xu, T.
    Li, Q.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (03) : 286 - 293
  • [35] Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study
    Nishimoto, Koji
    Karayama, Masato
    Inui, Naoki
    Yasui, Hideki
    Hozumi, Hironao
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Inami, Nao
    Matsuura, Shun
    Kaida, Yusuke
    Matsui, Takashi
    Asada, Kazuhiro
    Matsuda, Hiroyuki
    Fujii, Masato
    Toyoshima, Mikio
    Imokawa, Shiro
    Suda, Takafumi
    MEDICAL ONCOLOGY, 2018, 35 (07)
  • [36] Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Naito, Yoshiko
    Matsuo, Norikazu
    Ishii, Hidenobu
    Tokito, Takaaki
    Azuma, Koichi
    Ichiki, Masao
    Hoshino, Tomoaki
    ANTICANCER RESEARCH, 2018, 38 (06) : 3779 - 3784
  • [37] Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer
    Zhao, Xinmin
    Yu, Hui
    Zhao, Jing
    Wu, Xianghua
    Sun, Si
    Luo, Zhiguo
    Wang, Huijie
    Qiao, Jie
    Chang, Jianhua
    Wang, Jialei
    ONCOTARGET, 2017, 8 (49) : 86384 - 86394
  • [38] Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
    Kawano, Yuko
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Tanimoto, Azusa
    Nishizawa, Hironari
    Ichikawa, Atsuo
    Sakatani, Toshio
    Nakatomi, Katsumi
    Hagiwara, Sachiko
    Ninomiya, Hironori
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2013, 33 (08) : 3327 - 3333
  • [39] Randomized Phase II Study of Docetaxel plus Bevacizumab or Pemetrexed plus Bevacizumab for Elderly Non-Squamous NSCLC (TORG1323)
    Kozuki, Toshiyuki
    Nogami, Naoyuki
    Yamashita, Natsumi
    Shinkai, Tetsu
    Shukuya, Takehito
    Seki, Nobuhiko
    Kato, Terufumi
    Satouchi, Miyako
    Masuda, Noriyuki
    Watanabe, Koshiro
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S666 - S666
  • [40] Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer
    Kaira, Kyoichi
    Tomizawa, Yoshio
    Yoshino, Reiko
    Miura, Yosuke
    Yoshii, Akihiro
    Iwasaki, Yasuki
    Koga, Yasuhiko
    Ono, Akihiro
    Hisada, Takeshi
    Minato, Koichi
    Sato, Koji
    Kazama, Toshifumi
    Ishihara, Shinichi
    Kohyama, Kenya
    Fueki, Naoto
    Saito, Ryusei
    Sunaga, Noriaki
    LUNG CANCER, 2013, 82 (01) : 103 - 108
12345